A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients

Complementary Therapies in Medicine

Volumn 17, Issue 2, 2009, Pages 92-120

  Molassiotis, A ^a   Potrata, B ^a   Cheng, K K F ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Chinese; Herbs; Phytotherapy; Quality of life; Survival; Toxicity

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASTRAGALUS EXTRACT; BN 165; BU ZHONG YI QI TANG; CHINESE DRUG; CISPLATIN; DAI KENCHU TO; FEI AI CHONG JI; FLUOROURACIL; FUSHENG YILIU; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HANGE SHASHIN TO; HERBACEOUS AGENT; IRINOTECAN; LIUWEIDIHUANG TANG; LOMUSTINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PLATINUM COMPLEX; PU TUO; QING WEI SAN; SHEN YANG; SHENMAI; SHI QUAN DA BU TANG; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; YU NU JIAN; ZHENQI FUZHENG; ZHENXIANG;

ABSENCE OF SIDE EFFECTS; ALOPECIA; ARTIFICIAL EMBOLISM; BLOOD CELL COUNT; BLOOD TOXICITY; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; BONE METASTASIS; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHINESE MEDICINE; CLINICAL TRIAL; COBALT THERAPY; COLON CANCER; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; HEAD AND NECK CANCER; HERBAL MEDICINE; HUMAN; INTESTINE SURGERY; KIDNEY FUNCTION; LARGE INTESTINE CANCER; LEUKEMIA; LEUKOCYTE COUNT; LEUKOPENIA; LIVER CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LUNG NON SMALL CELL CANCER; MONOTHERAPY; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEOPLASM; ORAL MUCOSAL DISEASE; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PATIENT COMPLIANCE; QUALITY OF LIFE; RADIATION PNEUMONIA; REVIEW; SIDE EFFECT; STOMACH CANCER; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; TOTAL STOMACH RESECTION; TUMOR REGRESSION; UNSPECIFIED SIDE EFFECT;

CLINICAL TRIALS AS TOPIC; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; PHYTOTHERAPY; QUALITY OF LIFE;

EID: 58549117282     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2008.11.002     Document Type: Review

References (88)

1. Molassiotis A., Fernadez-Ortega P., Pud D., Ozden G., Scott J., Panteli V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncology 16 4 (2005) 655-663
2. Kessler R.C., Davis R.B., Foster D.F., van Rompay M.I., Walters E.E., Wilkey S.A., et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Annals of Internal Medicine 135 4 (2001) 262-268
3. Lengacher C.A., Bennet M.P., Kip K.E., Keller R., LaVance M.S., Smith L.S., et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncology Nursing Forum 29 10 (2002) 1445-1452
4. Dobos G.J., Tan L., Cohen M.H., McIntyre M., Bauer R., Li X., et al. Are national quality standards for traditional Chinese herbal medicine sufficient?: Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country. Complementary Therapies in Medicine 13 3 (2005) 183-190
5. Ruan W., Lai M., and Zhou J. Anticancer effects of Chinese herbal medicine, science or myth?. Journal of Zhejiang University Science B 7 12 (2006) 1006-1014
6. Jia W., Gao W.-Y., Wang T., Liu Y.-B., Xue J., and Xiao P.-G. Cataplasma of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 28 1 (2003) 10-11
7. Gan T., Jin S., Tian L., and Wang Y. Traditional Chinese medicinal herbs for induction of remission in advanced or late gastric cancer. The Cochrane Database of Systematic Reviews (2005)
8. Blumenthal M. Guest editorial: the rise and fall of PC-SPES: new generation of herbal supplement, adulterated product, or new drug. Integrative Cancer Therapies 1 3 (2002) 266-270
9. Liu X., Zsang M., Li J., and Qin M. Chinese herbs for symptom palliation in patients with lung cancer. The Cochrane Database of Systematic Reviews (2004)
10. Rafailov S., Cammack S., Stone B., and Katz A. The role of Zyflamend, an herbal anti-inflammatory, as a potential chemopreventive agent against prostate cancer: a case report. Integrative Cancer Therapies 6 1 (2007) 74-76
11. Mahady G. Global harmonisation of herbal health claims. Journal of Nutrition 131 (2001) 1120S-1123S
12. Lynch N., and Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complementary Therapies in Medicine 15 2 (2007) 84-91
13. Tomassoni A.J., and Simone K. Herbal medicines for children: an illusion of safety?. Current Opinion in Paediatrics 13 (2001) 162-169
14. Fong H. Integration of herbal medicine into modern medical practices: issues and prospects. Integrative Cancer Therapies 1 3 (2002) 287-293
15. Wachtel-Galor S., Tomlinson B., and Benzie I. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. British Journal of Nutrition 91 (2004) 263-269
16. Werneke U., Ladenheim D., and McCarthy T. Complementary alternative medicine for cancer: a review of effectiveness and safety. Cancer Therapy 2 (2004) 475-500
17. Yarnell E., and Abascal K. Overview of drug-herb interactions. Alternative & Complementary Therapies 8 (2002) 87-96
18. Block K., and Gyllenhaal C. Herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integrative Cancer Therapies 1 (2002) 83-89
19. Taixiang W., Wei X., Yang X., and Zhiyu C. Medicinal herbs for esophageal cancer. Cochrane Database System Review 24 1 (2007) CD004520
20. World Health Organisation. General guidelines for methodologies on research and evaluation of traditional medicine. WHO/EDM/TRM/2000.1 ed. (2000), World Health Organisation
21. Jadad A., Moore R., Carroll D., Jenkinson C., Reynolds D., Gavaghan D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 17 1 (1996) 1-12
22. Mok T., Yeo W., Johnson P., Hui P., Ho W., Lam K., et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Annals of Oncology 18 4 (2007) 768-774
23. McCulloch M., See C., Shu X.J., Broffman M., Kramer A., Fan W.Y., et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Journal of Clinical Oncology 24 3 (2006) 419-430
24. Duan P., and Wang Z. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 22 7 (2002) 515-517
25. Zhou D., and Lin L. Effect of Jinshuibao capsule on the immunological function of 36 patients with advanced cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 15 8 (1995) 476-478
26. Cai H., Dai F., Min Q., Shi M., and Miao J. RCL clinical study of the effects of radiotherapy in combination with traditional Chinese medicine on non-small cell lung cancer. Di Yi Jun Yi Da Xue Xue Bao. Academic Journal of the First Medical College of PLA 22 2 (2002) 1112-1113
27. Guo X., Li J., and Yang X. Clinical observation on 112 cases with non-Hodgkin's lymphoma treated by Chinese herbs combined with chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 17 6 (1997) 325-327
28. Cluzan R., Pecking A., Mathiex-Fortunet H., and Léger Picherit E. Efficacy of BN165 (Ginkor Fort) in breast cancer related upper limb lymphedema: a preliminary study. Lymphology 37 2 (2004) 47-52
29. Guo Z. Clinical observation on treatment of 38 cases of postoperational large intestinal cancer by Fuzheng Yiai decoction combined with chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 19 1 (1999) 20-22
30. Horie Y., Kato K., Kameoka S., and Hamano K. Bu ji (hozai) for treatment of postoperative gastric cancer patients. American Journal of Chinese Medicine 22 3-4 (1994) 309-319
31. Li X., Zhou Y., and Jiao Z. Clinical study on post-operational anti-metastasis effect of xiaoliu pingyi mixture. Zhongguo Zhong Xi Yi Jie He Za Zhi 21 5 (2001) 335-338
32. Wang B., Liu X., and Wang T. Study of prevention and treatment on acute radioactive injury with huoxue yiqi yangyin recipe. Zhongguo Zhong Xi Yi Jie He Za Zhi. 20 3 (2000) 180-182
33. Jiang L., and Han Y. Relieving cancerous pain and improving the survival quality with fei ai chong ji. Journal of Tradititional Chinese Medicine 16 2 (1996) 98-100
34. Liu J., and Wu D. 32 cases of postoperative osteogenic sarcoma treated by chemotherapy combined with Chinese medicinal herbs. Zhongguo Zhong Xi Yi Jie He Za Zhi 13 3 (1993) 150-152 132
35. Liu X., Wang B., and Fu X. Clinical study on treatment of advanced non-small cell lung cancer with Chinese herbal medicine combined with synchronous radio-and chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 20 6 (2000A) 427-429
36. Tan D., Xie Z., and Zhong H. A clinical observation on the leukopenia treated with shengbaikuai decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi 18 7 (1998) 408-410
37. Xu K., Luo H., and Li L. Clinical study on comprehensive treatment of primary liver cancer mainly with chinese medicinal perfusion/embolization. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 4 (2005) 299-302
38. Zhang B., Hu P., Qiu H., Qian S., Chen X., and Huang G. Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy. Ai Zheng 23 Suppl. 11 (2004) 1470-1472
39. Zhu H., and Zhang J. Treatment of stomatological complications in 31 cases of acute leukemia with Chinese herbal drugs. Journal of Traditional Chinese Medicine 13 4 (1993) 253-256
40. Endo S., Nishida T., Nishikawa K., Nakajima K., Hasegawa J., Kitagawa T., et al. Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. American Journal of Surgery 192 1 (2006) 9-13
41. Wang D. Analysis of 70 cases of primary liver carcinoma treated by pu tuo ointment and herbs. Zhong Xi Yi Jie He Za Zhi 10 12 (1990B) 723-725 708
42. Liu P., Cao Y., and Qiao X. Clinical study on shenmai injection in promoting postoperative recovery in patients of breast cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 20 5 (2000B) 328-329
43. Zhu B. Observation on 17 patients of radio-ulcer with combined traditional Chinese medicine and Western medicine therapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 14 2 (1994) 89-91
44. Pan B., Cheng T., Nan K., Qiu G., and Sun X. Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer. World Journal of Gastroenterology 21 11 (2005) 439-442
45. Yu Q., Zhang F., and Tang X. Clinical study on early use of Chinese medicinal herbs and chemotherapy after operation of gastric cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 15 8 (1995) 459-461
46. Mori K., Kondo T., Kamiyama Y., Kano Y., and Tominaga K. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology 51 5 (2003) 403-406
47. Xu X., Zhou X., and Wang J. Radiotherapy combined with intervention treatment for patients with advanced cancer: a randomized study in 60 cases. Zhonghue Zhong Liu Za Zhi 20 5 (1998) 394-395
48. Liu F., Liu S., and Ren Z. Clinical observation on treatment of multiple bone metastatic tumor of mammary cancer by combination therapy of 89Sr and Chinese herbal medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 4 (2003) 257-265
49. Liu C., Liu L., Zhang L., Su X., and Yen B. Chinese herbs for strengthening the body resistance and daoyin exercise in the improvement of life quality among lung cancer patients. Chinese Journal of Clinical Rehabilitation 9 18 (2005A) 251-253
50. Li J., Li X., and Li J. Clinical and experimental study on Fuzheng Baozhen decoction enhancing effect of radio- and chemotherapy for malignant tumors. Zhongguo Zhong Xi Yi Jie He Za Zhi 18 9 (1998) 523-526
51. Li R., Lu P., Kou X.-G., and Xi H.-J. Effect of the intervention of traditional Chinese medicine on the survival time and quality of life in postoperative patients with esophageal cancer. Chinese Journal of Clinical Rehabilitation 9 42 (2005) 63-65
52. Wang B., Liu X., and Fu X. Clinical observation on effect of yiqi huoxue decoction in comprehensive treatment on advanced stage of esophageal cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 19 10 (1999) 589-591
53. Abernethy A., Shelby-James T., Fazekas B.S., Woods D., and Currow D. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice. BMC Palliative Care 7 (2005) nr
54. Mor V., Laliberte L., Morris J., and Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53 (2002) 2002-2007
55. Nikoletti S., Porock D., Kristjanson L., Medigovich K., Pedler P., and Smith M. Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale. Journal of Palliative Medicine 3 (2000) 301-311
56. Liu J., Wang W., and Zhou Y. Observation on therapeutic effect of jianpi huoxue herbs combined with chemotherapy in treating post-operational colonic cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 (2005B) 207-209
57. Meng Z., Xu Y., Liu L., Song M., and Huang W. Clinical evaluation of integration of trascatheter arterial chemoembolisation and traditional Chinese medicine in treating metastatic liver cancer. Zhong Xi Yi Jie He Xue Bao 1 3 (2003) 187-188 233
58. Cluzon R., Pecking A., Mathiex-Fortunet H., and Léger Picherit E. Efficacy of BN165 (Ginkor Fort) in breast cancer related upper limb lymphedema: a preliminary study. Lymphology 37 2 (2004) 47-52
59. Hu Y., Wu C., Liu Y., Wang Y., Li X., Zhong H., et al. Clinical observation on effect of shenqi fanghou recipe in preventing and treating radiation injury in patients with head and neck tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 7 (2005) 623-625
60. Li H., Li H., and Tang Z. Effect of Chang'at Kangfu decoction on Immunity in postoperational patients with large intestine cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 20 8 (2000) 580-582
61. Zeng X., and Zou X. Lung cancer treated by acupuncture-moxibustion combined with traditional chinese medicine: 40 cases. International Journal of Clinical Acupuncture 12 4 (2002) 371-373
62. Lan X., and Jiang Y. The therapeutic effects of the radiotherapy plus TCM treatment observed in senile non-parvicellular lung cancer patients at the late stage. Journal of Traditional Chinese Medicine 23 1 (2003) 32-34
63. Li Q., Cao S., Xie G., Gan Y., Ma H., Lu J., et al. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphing on postoperative pain in liver cancer. Chinese Medical Journal 107 4 (1994) 289-294
64. Zhou K., Wang J., and Liu B. Clinical study on effect of shenqi fuzheng injection combined with chemotherapy in treating gastric cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 19 1 (1999) 11-13
65. Huang Z.M., and Long H. Therapeutic effect of Chinese medicinal herbs combined with chemotherapy on advanced non-small cell lung cancer. Zhongguo zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi 17 1 (1997) 26-28
66. Suh S., Kroh M., Kim N., Joh Y., and Cho M. Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. American Journal of Chinese Medicine 30 4 (2002) 483-494
67. Zhao A.-G., Cai Y., Yang J.-K., Zheng J., and Shen K.-P. Effect of Chinese jianpi herbs on prognosis of gastric cancer. World Chinese Journal of Digestology 13 9 (2005) 1055-1058
68. Wang G. Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals. Zhong Xi Yi Jie He Za Zhi 10 12 (1990A) 712-716 707
69. Chen J. Clinical effect of chemotherapy combined with Chinese herbs and western drugs on leukocytes of gastric cancer patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 10 12 (1990) 717-719 707
70. Cheng J. Clinical study on prevention and treatment to chemotherapy caused nephrotoxicity with jian-pi yi-qi li-shui decoction. Zhongguo zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi 14 6 (1994) 331-333 323
71. Xu B., Zhang Y., and Li S. Effect of relieving blood stasis, strengthening spleen and soothing liver therapy in improving hepatic function in patients after liver-carcinomectomy. Zhongguo Zhong Xi Yi Jie He Za Zhi 21 10 (2001) 742-743
72. Yu Q., Chen Z., and Tang X. Study on early application of Chinese medicinal herbs after total gastrectomy. Zhongguo zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi 19 10 (1999) 592-594
73. Mi Y., Hu Y., and Zhou M. Study of relationship between level of serum selenium and syndrome differentiation and typing of traditional Chinese medicine in lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 15 11 (1995) 658-660
74. Wong C., Bao Y., Wong E., Leung P., Fung K., and Lam C. Immunomodulatory activities of yunzhi and danshen in post-treatment breast cancer patients. American Journal of Chinese Medicine 33 3 (2005) 381-395
75. Yu Q., Liu Y., Hou Y., Zhang F., Yi W., Wang X., et al. Effect of early intestinal dripping of jianpi tongli Chinese herbs on serum level IL-2, sIL-2R and IL-12 in patients with gastric cancer after operation. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi 25 8 (2005) 710-713
76. Zhang B., Hu P., Qiu H., Qian S., Chen X., and Huang G. Observation of clinical response of "sheng ban recipe" for platelets decrease after chemotherapy. Ai Zheng 23 11 (2004) 1470-1472
77. Lin G., Qiu W., Lu C., Guo Y., Cao Y., Guralnick W., et al. Long term follow-up results of Chinese prescription "Shen Yang" in the combined and sequential treatment of oral squamous cell carcinoma. Shanghai Kou Qiang Yi Xue 12 5 (2003) 321-323
78. Cardini F., Wade C., Regalia A., Gui S., Li W., Raschetti R., et al. Clinical research in traditional medicine: priorities and methods. Complementary Therapies in Medicine 14 (2004) 282-287
79. Verhoef M., Lewith G., Ritenbaugh C., Boon H., Fleishman S., and Leis A. Complementary and alternative medicine whole systems research: Beyond identification of inadequacies of the RCT. Complementary Therapies in Medicine 13 (2005) 206-212
80. Moerman D. Meaning, medicine and the "placebo" effect (2002), Cambridge University Press, Cambridge
81. Zheng C., Feng G., and Zhou R. New use of Bletilla striata as embolizing agent in the intervention treatment of hepatic carcinoma. Chinese Journal of Oncology 18 4 (1996) 305-307
82. Wang G. Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals. Zhong Xi Yi Jie He Za Zhi 10 12 (1990) 712-716 707
83. Taixiang W., Munro A., and Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. The Cochrane Database of Systematic Reviews (2004)
84. Wei X., Chen Z., Yang X., and Wu T.X. Medicinal herbs for esophageal cancer. The Cochrane Database of Systematic Reviews 3 (2007) CD004520
85. Zhang M., Liu X., Li J., He L., and Tripathy D. Chinese medicinal herbs to treat the side effects of chemotherapy in breast cancer patients. The Cochrane Database of Systematic Reviews (John Wiley and Sons, Ltd.) (2007)
86. Shu X., McCulloch M., Xiao H., Broffman M., and Gao J. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integrative Cancer Therapies 4 3 (2005) 219-229
87. Gao X.P., Zhao W.X., and Zhang Z.L. Effect of huangqi zengmian powder on interstitial response in patients with esophageal cancer at peri-operational period. Zhongguo Zhong Xi Yi Jie He Za Zhi 21 3 (2001) 171-173
88. Zou Y.H., and Liu X.M. Effect of Astragalus injection combined with chemotherapy on quality of life in patients with advanced nonsmall cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 (2003) 733-735